A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss

Clinical trial NCT06909123 · WITHDRAWN

Trial details

NCT number: NCT06909123
Sponsor: Stanford University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lactation Suppressed

Start date: 2026-07-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.